Seeking Alpha

Regeneron Pharmaceuticals (REGN -0.7%) announces that the FDA has approved Eylea Injection for...

Regeneron Pharmaceuticals (REGN -0.7%) announces that the FDA has approved Eylea Injection for the treatment of macular edema. The approval was based on data from Phase 3 studies which showed results for Eylea were superior to those for the sham control group for the primary endpoint.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs